TAK — Takeda Pharmaceutical Company Limited stock price, charts and financials

QT42Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (NYSE: TAK) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
16.56
-0.27-1.60%
OverviewShort InterestFilings
TAKQT42Takeda Pharmaceutical Company Limited·NYSE
16.56-1.60%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 30, 20266-KForeign issuer report
Jul 09, 20266-KForeign issuer report
Jul 08, 20266-KForeign issuer report
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20263Initial statement of beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20263Initial statement of beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20263Initial statement of beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
#1 / 25 of 375
Page
▼
/ 15